• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在诊断的灰色地带中前行:一例具有挑战性的胰腺高级别神经内分泌肿瘤病例。

Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.

机构信息

Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, 02114, Boston, MA, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Diagn Pathol. 2024 Sep 12;19(1):123. doi: 10.1186/s13000-024-01546-6.

DOI:10.1186/s13000-024-01546-6
PMID:39267076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391758/
Abstract

BACKGROUND

Grade 3 neuroendocrine tumor (G3 PanNET) and poorly differentiated neuroendocrine carcinoma (PanNEC) of the pancreas are considered distinct entities from a biological and prognostic perspective but may have overlapping features complicating a definitive diagnosis.

CASE PRESENTATION

A 52-year-old female presented with a pancreatic body mass and liver lesions. Initial biopsies showed variable lower- and higher-grade morphologies and modestly elevated Ki67 proliferation index up to 30%, leading to a diagnosis of G3 PanNET. The patient underwent everolimus treatment followed by surgical resection, revealing a complex tumor with features of both G3 PanNET and PanNEC, including admixed well- and poorly differentiated morphologies, modestly elevated hotspot Ki67 of 28%, retained ATRX/DAXX expression, and loss of RB expression. The final diagnosis rendered was "high-grade neuroendocrine neoplasm" with discussion of both entities in the differential. Post-operatively, the patient remains alive with stable metastases.

CONCLUSIONS

This case highlights the diagnostic complexities of distinguishing G3 PanNET and PanNEC even with the support of ancillary immunohistochemical and molecular studies. In addition, such cases raise the possibility that G3 PanNET and PanNEC may lie on a spectrum of disease with potential biological overlap.

摘要

背景

3 级神经内分泌肿瘤(G3 胰腺神经内分泌肿瘤)和分化差的胰腺神经内分泌癌(PanNEC)从生物学和预后的角度来看被认为是不同的实体,但可能具有重叠的特征,使明确诊断变得复杂。

病例介绍

一名 52 岁女性因胰腺体肿块和肝脏病变就诊。初始活检显示形态学存在可变的低级别和高级别,Ki67 增殖指数适度升高至 30%,导致 G3 胰腺神经内分泌肿瘤的诊断。患者接受了依维莫司治疗,随后进行了手术切除,发现肿瘤具有 G3 胰腺神经内分泌肿瘤和 PanNEC 的特征,包括混合的良好和低度分化形态学,适度升高的热点 Ki67 为 28%,保留 ATRX/DAXX 表达,以及 RB 表达缺失。最终诊断为“高级别神经内分泌肿瘤”,并在鉴别诊断中讨论了这两种肿瘤。术后,患者仍存活且转移稳定。

结论

即使有辅助免疫组织化学和分子研究的支持,本病例也强调了区分 G3 胰腺神经内分泌肿瘤和 PanNEC 的诊断复杂性。此外,此类病例提出了 G3 胰腺神经内分泌肿瘤和 PanNEC 可能处于疾病谱上的可能性,存在潜在的生物学重叠。

相似文献

1
Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.在诊断的灰色地带中前行:一例具有挑战性的胰腺高级别神经内分泌肿瘤病例。
Diagn Pathol. 2024 Sep 12;19(1):123. doi: 10.1186/s13000-024-01546-6.
2
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.综合基因组和临床病理方法可区分胰腺 3 级神经内分泌肿瘤与神经内分泌癌,并确定一组具有分子重叠的肿瘤。
Mod Pathol. 2023 Mar;36(3):100065. doi: 10.1016/j.modpat.2022.100065. Epub 2023 Jan 10.
3
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
4
Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.韩国人群胰腺高级别神经内分泌肿瘤:一项多中心研究。
Cancer Res Treat. 2020 Jan;52(1):263-276. doi: 10.4143/crt.2019.192. Epub 2019 Jul 12.
5
Diagnostic and prognostic biomarkers for pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤的诊断和预后生物标志物
Pathologie (Heidelb). 2024 Nov;45(Suppl 1):74-82. doi: 10.1007/s00292-024-01393-8. Epub 2024 Nov 18.
6
Prognostic and predictive significance of p53 and ATRX in neuroendocrine neoplasms of GIT and pancreas and their utility as an adjunct to accurate diagnosis-An eight-year retrospective study.p53和ATRX在胃肠道及胰腺神经内分泌肿瘤中的预后和预测意义及其作为准确诊断辅助手段的效用——一项八年回顾性研究
Indian J Gastroenterol. 2025 Feb;44(1):95-102. doi: 10.1007/s12664-024-01678-z. Epub 2024 Oct 1.
7
Assessment of cytologic differentiation in high-grade pancreatic neuroendocrine neoplasms: A multi-institutional study.高级胰腺神经内分泌肿瘤的细胞学分化评估:一项多机构研究。
Cancer Cytopathol. 2018 Jan;126(1):44-53. doi: 10.1002/cncy.21934. Epub 2017 Oct 17.
8
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
9
[Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].[免疫组织化学在胰腺神经内分泌肿瘤中的实际应用:技巧与陷阱]
Pathologie (Heidelb). 2024 Feb;45(1):35-41. doi: 10.1007/s00292-023-01276-4. Epub 2024 Jan 4.
10
Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.胃肠胰高级别神经内分泌肿瘤:组织学与分子分析,一枚硬币的两面。
Neuroendocrinology. 2020;110(7-8):616-629. doi: 10.1159/000503722. Epub 2019 Sep 27.

本文引用的文献

1
An Illustrated Review of the Recent 2019 World Health Organization Classification of Neuroendocrine Neoplasms: A Radiologic and Pathologic Correlation.《近期 2019 年世界卫生组织神经内分泌肿瘤分类的图示复习:放射与病理关联》
J Comput Assist Tomogr. 2024;48(4):601-613. doi: 10.1097/RCT.0000000000001593. Epub 2024 Feb 26.
2
Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.综合基因组和临床病理方法可区分胰腺 3 级神经内分泌肿瘤与神经内分泌癌,并确定一组具有分子重叠的肿瘤。
Mod Pathol. 2023 Mar;36(3):100065. doi: 10.1016/j.modpat.2022.100065. Epub 2023 Jan 10.
3
Case 23-2022: A 49-Year-Old Man with Hypoglycemia.
病例23 - 2022:一名49岁的低血糖男性。
N Engl J Med. 2022 Jul 28;387(4):356-365. doi: 10.1056/NEJMcpc2115858.
4
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study.法国一项针对进展期不可切除或转移性高分化胰腺神经内分泌肿瘤(pNETs)全身治疗中靶向治疗的真实世界观察性研究:OPALINE 研究。
Adv Ther. 2022 Jun;39(6):2731-2748. doi: 10.1007/s12325-022-02103-7. Epub 2022 Apr 13.
5
The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.宫颈小细胞神经内分泌癌相关基因的下一代测序。
Gynecol Oncol. 2021 Jun;161(3):779-786. doi: 10.1016/j.ygyno.2021.04.019. Epub 2021 May 1.
6
SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.SMARCA4(BRG1)和 SMARCB1(INI1)在 TTF-1 阴性神经内分泌癌中的表达,包括 Merkel 细胞癌。
Pathol Res Pract. 2021 Mar;219:153341. doi: 10.1016/j.prp.2021.153341. Epub 2021 Jan 10.
7
Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon.胰腺神经内分泌肿瘤:现状与展望。
Arch Pathol Lab Med. 2020 Jul 1;144(7):816-828. doi: 10.5858/arpa.2019-0654-RA.
8
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.大细胞神经内分泌癌的综合基因组分析揭示了高级别神经内分泌肺肿瘤的不同亚型。
Nat Commun. 2018 Mar 13;9(1):1048. doi: 10.1038/s41467-018-03099-x.
9
Effect of everolimus on the expression of Ki-67 and caspase-3 in patients with neuroendocrine tumors.依维莫司对神经内分泌肿瘤患者Ki-67和半胱天冬酶-3表达的影响。
Genet Mol Res. 2017 Mar 30;16(1):gmr-16-01-gmr.16019486. doi: 10.4238/gmr16019486.
10
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.